.Pharmacolibrary.Drugs.P_AntiparasiticProductsInsecticidesAndRepellents.P01C_AgentsAgainstLeishmaniasisAndTrypanosomiasis.P01CB01_MeglumineAntimonate.MeglumineAntimonate .Pharmacolibrary.Drugs.P_AntiparasiticProductsInsecticidesAndRepellents.P01C_AgentsAgainstLeishmaniasisAndTrypanosomiasis.P01CB01_MeglumineAntimonate.MeglumineAntimonate| name: | MeglumineAntimonate |
| ATC code: | P01CB01 | route: | intramuscular |
| n-compartments | 2 |
Meglumine antimonate is a pentavalent antimonial compound historically used in the treatment of leishmaniasis, a parasitic disease. It is administered parenterally and is no longer the first-line therapy in many settings due to toxicity and the development of newer drugs.
Pharmacokinetic parameters reported in adults with cutaneous leishmaniasis after intramuscular administration.